BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36782375)

  • 1. The activation of EP300 by F11R leads to EMT and acts as a prognostic factor in triple-negative breast cancers.
    Li CH; Fang CY; Chan MH; Lu PJ; Ger LP; Chu JS; Chang YC; Chen CL; Hsiao M
    J Pathol Clin Res; 2023 May; 9(3):165-181. PubMed ID: 36782375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional inhibition of F11 receptor (F11R/junctional adhesion molecule-A/JAM-A) activity by a F11R-derived peptide in breast cancer and its microenvironment.
    Bednarek R; Selmi A; Wojkowska D; Karolczak K; Popielarski M; Stasiak M; Salifu MO; Babinska A; Swiatkowska M
    Breast Cancer Res Treat; 2020 Jan; 179(2):325-335. PubMed ID: 31650345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The F11 Receptor (F11R)/Junctional Adhesion Molecule-A (JAM-A) (F11R/JAM-A) in cancer progression.
    Czubak-Prowizor K; Babinska A; Swiatkowska M
    Mol Cell Biochem; 2022 Jan; 477(1):79-98. PubMed ID: 34533648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic structure, organization and promoter analysis of the human F11R/F11 receptor/junctional adhesion molecule-1/JAM-A.
    Sobocki T; Sobocka MB; Babinska A; Ehrlich YH; Banerjee P; Kornecki E
    Gene; 2006 Jan; 366(1):128-44. PubMed ID: 16337094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The F11 receptor (F11R/JAM-A) in atherothrombosis: overexpression of F11R in atherosclerotic plaques.
    Babinska A; Azari BM; Salifu MO; Liu R; Jiang XC; Sobocka MB; Boo D; Al Khoury G; Deitch JS; Marmur JD; Ehrlich YH; Kornecki E
    Thromb Haemost; 2007 Feb; 97(2):272-81. PubMed ID: 17264957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription and translation of human F11R gene are required for an initial step of atherogenesis induced by inflammatory cytokines.
    Azari BM; Marmur JD; Salifu MO; Ehrlich YH; Kornecki E; Babinska A
    J Transl Med; 2011 Jun; 9():98. PubMed ID: 21703019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of F11R polymorphisms and gene expression with primary Sjögren's syndrome patients.
    Fang TJ; Li RN; Lin YZ; Lin CH; Tseng CC; Sung WY; Ou TT; Wu CC; Yen JH
    Int J Rheum Dis; 2021 May; 24(5):681-686. PubMed ID: 33780157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling pathways of the F11 receptor (F11R; a.k.a. JAM-1, JAM-A) in human platelets: F11R dimerization, phosphorylation and complex formation with the integrin GPIIIa.
    Sobocka MB; Sobocki T; Babinska A; Hartwig JH; Li M; Ehrlich YH; Kornecki E
    J Recept Signal Transduct Res; 2004 Feb; 24(1-2):85-105. PubMed ID: 15344881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of a recombinant protein of the platelet F11 receptor (F11R) (JAM-1/JAM-A) in insect cells: F11R is naturally phosphorylated in the extracellular domain.
    Kedees MH; Babinska A; Swiatkowska M; Deitch J; Hussain MM; Ehrlich YH; Kornecki E
    Platelets; 2005 Mar; 16(2):99-109. PubMed ID: 15823866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F11R mRNA expression and promoter polymorphisms in patients with rheumatoid arthritis.
    Fang TJ; Lin CH; Lin YZ; Li RN; Ou TT; Wu CC; Tsai WC; Yen JH
    Int J Rheum Dis; 2016 Feb; 19(2):127-33. PubMed ID: 26230081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Junctional adhesion molecule-A is co-expressed with HER2 in breast tumors and acts as a novel regulator of HER2 protein degradation and signaling.
    Brennan K; McSherry EA; Hudson L; Kay EW; Hill AD; Young LS; Hopkins AM
    Oncogene; 2013 May; 32(22):2799-804. PubMed ID: 22751120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of plasma levels of F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) with human atherosclerosis.
    Cavusoglu E; Kornecki E; Sobocka MB; Babinska A; Ehrlich YH; Chopra V; Yanamadala S; Ruwende C; Salifu MO; Clark LT; Eng C; Pinsky DJ; Marmur JD
    J Am Coll Cardiol; 2007 Oct; 50(18):1768-76. PubMed ID: 17964041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. F11R/JAM-A: why do platelets express a molecule which is also present in tight junctions?
    Kamola P; Babinska A; Przygodzki T
    Platelets; 2023 Dec; 34(1):2214618. PubMed ID: 37246517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two regions of the human platelet F11-receptor (F11R) are critical for platelet aggregation, potentiation and adhesion.
    Babinska A; Kedees MH; Athar H; Sobocki T; Sobocka MB; Ahmed T; Ehrlich YH; Hussain MM; Kornecki E
    Thromb Haemost; 2002 Apr; 87(4):712-21. PubMed ID: 12008956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of the F11R gene reveals a role for F11R/JAM-A in the migration of inflamed vascular smooth muscle cells and in atherosclerosis.
    Azari BM; Marmur JD; Salifu MO; Cavusoglu E; Ehrlich YH; Kornecki E; Babinska A
    Atherosclerosis; 2010 Sep; 212(1):197-205. PubMed ID: 20627246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer.
    Ring A; Kaur P; Lang JE
    BMC Cancer; 2020 Nov; 20(1):1076. PubMed ID: 33167919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated plasma level of soluble F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) in hypertension.
    Ong KL; Leung RY; Babinska A; Salifu MO; Ehrlich YH; Kornecki E; Wong LY; Tso AW; Cherny SS; Sham PC; Lam TH; Lam KS; Cheung BM
    Am J Hypertens; 2009 May; 22(5):500-5. PubMed ID: 19214165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINC01146/F11R facilitates growth and metastasis of prostate cancer under the regulation of TGF-β.
    Guo X; Gu Y; Guo C; Pei L; Hao C
    J Steroid Biochem Mol Biol; 2023 Jan; 225():106193. PubMed ID: 36162632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A peptide antagonist of F11R/JAM-A reduces plaque formation and prolongs survival in an animal model of atherosclerosis.
    Babinska A; Clement CC; Przygodzki T; Talar M; Li Y; Braun M; Wzorek J; Swiatkowska M; Ehrlich YH; Kornecki E; Watala C; Salifu MO
    Atherosclerosis; 2019 May; 284():92-101. PubMed ID: 30877938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Subtyping of Triple-Negative Breast Cancers by Immunohistochemistry: Molecular Basis and Clinical Relevance.
    Zhao S; Ma D; Xiao Y; Li XM; Ma JL; Zhang H; Xu XL; Lv H; Jiang WH; Yang WT; Jiang YZ; Zhang QY; Shao ZM
    Oncologist; 2020 Oct; 25(10):e1481-e1491. PubMed ID: 32406563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.